iOS app Android app

Corporate Immunity

Reglan Lawsuits Continue to Drive Debate Over Corporate Immunity, Generic Preemption

Edward F. Blizzard | Posted 05.25.2011 | Business
Edward F. Blizzard

The Supreme Court is currently awaiting word from the Obama administration regarding its position on generic drug manufacturers' claims that federal regulation of prescription drugs grants them immunity from lawsuits in state courts.